Cannabis Stocks Snapshot
There has been so much in the news lately about cannabis stocks, we though it would be cool to put together a quick snapshot of the more talked-about companies out there. While certainly not a complete list, and DEFINITELY not a recommendation for or against anything, this is just a primer into the various businesses, market shares, and revenues for some of the players we keep hearing about in the news.
India Globalization (NYSE: IGC)
Summary
According to their own website (http://www.igcinc.us): They have two businesses:
The first is a legacy infrastructure business that consists of heavy equipment rental, real estate management, and trading commodities like ore and building materials. most of this business is conducted in our subsidiary TBL.
The second is a U.S. based cannabis pharmaceutical business focused on using cannabis extracts for the treatment of many diseases: IGC Pharma (https://igcpharma.com). Phyto cannabinoid-based products are aimed at improving the lives of people battling Alzheimer’s disease, Parkinson’s disease, chronic pain, PTSD, and eating disorders.
Numbers (USD)
| Market Cap | 358,492,000 |
| Total Revenue (year ended 3/31/2018) | 2,192,590 |
| Gross Profit | 81,524 |
| Operating Income (Loss) | (1,788,953) |
| Last price (10/1/2018) | 9.02 |
| 52 Week high/low | 0.36 – 14.58 |
Tilray Inc. (NASDAQ: TLRY)
Summary
From their site (https://www.tilray.com): Tilray is a global leader in medical cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis company.
A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.
Numbers (USD)
| Market Cap | 15,066,000,000 |
| Total Revenue (year ended 3/31/2018) | 20,538,000 |
| Gross Profit | 11,377,000 |
| Operating Income (Loss) | (7,498,000) |
| Last price (10/1/2018) | 164.98 |
| 52 Week high/low | 20.10 – 300.00 |
Aurora Cannabis Inc. (OTC: ACBFF)
Summary
From their website (https://www.auroramj.com): Aurora Cannabis is a community minded, Canadian owned and operated company. Nestled in the shadow of the Rockies in Mountain View County, our plants are carefully brought to harvest in our purpose-built 55,200 square foot facility. Fed with water from the Canadian Rockies, cared for in a state-of-the-art facility designed to produce the cleanest, safest medical cannabis available on the market, we're proud of our facility, our team and our product. Cultivating, harvesting, and selling Canadian Medical Marijuana, Aurora is your best chance to experience the healing power of nature.
Numbers (USD)
| Market Cap | 9,036,000,000 |
| Total Revenue (year ended 6/30/2018) | 55,196,000 |
| Gross Profit | 43,519,000 |
| Operating Income (Loss) | (80,108,000) |
| Last price (10/1/2018) | 9.70 |
| 52 Week high/low | 2.11 - 12.30 |
Canopy Growth Corp. (NASDAQ: CGC)
Summary
From their website (https://www.canopygrowth.com): At Canopy Growth, we build brands designed to meet the diverse needs of Canadian and global cannabis consumers, while supporting those brands with the capacity footprint and supply chain infrastructure needed to succeed. They have brand such as Tweed, Spectrum Cannabis, DNA Genetics, Leafs by Snoop (yes, Snoop Dogg), Craftgrow, and more.
Numbers (USD)
| Market Cap | 10,801,000,000 |
| Total Revenue (year ended 3/31/2018) | 77,948,000 |
| Gross Profit | 74,192,000 |
| Operating Income (Loss) | (78,875,000) |
| Last price (10/1/2018) | 48.85 |
| 52 Week high/low | 16.74 - 56.60 |
Valens GroWorks Corp. (OTC: MYMSF)
Summary
From website (https://www.valensgroworks.com): We are a Canadian publicly traded cannabis company (CSE: VGW) executing on our “plants to premium extracted products” objectives through three wholly-owned subsidiaries located in the heart of British Columbia’s Okanagan Valley.
Our subsidiary Valens Agritech (“VAL”) focuses on cannabis extraction services and consumer products for domestic and international markets. Operating out of it’s recently expanded 25,000 square foot facility, VAL is commencing cannabis processing and sales under a Health Canada Dealer’s License, and is a late-stage LP applicant with GMP certification pending.
We are also committed to producing high quality, greenhouse cannabis flower through our wholly owned subsidiary Valens Farms (“FARMS“). Valens Farms is a purpose-built, 400,000 square foot greenhouse project near Armstrong, BC that will be used to cultivate cannabis using mono-cropping methodology for the purposes of being processed into Valens-branded premium cannabis oils at VAL.
Our third subsidiary, Supra THC Services (“Supra”), is a Health Canada licensed, ISO 17025 accredited, cannabis testing laboratory providing sector-leading analytical and proprietary services to Licensed Producers, ACMPR patients, and the natural health products industry. Supra THC has partnered with Thermo Fisher Scientific to develop a “Centre of Excellence in Plant Based Medicine Analytics” in Kelowna.
Numbers (USD)
| Market Cap | 102,871,000 |
| Total Revenue (year ended 11/30/2017) | 40,724 |
| Gross Profit | (463,200) |
| Operating Income (Loss) | (4,875,654) |
| Last price (10/1/2018) | 1.448 |
| 52 Week high/low | 0.8453 - 2.5469 |
Cronos Group Inc. (NASDAQ: CRON)
Summary
From website (https://thecronosgroup.com): We are a geographically diversified and vertically integrated cannabis group that operates within Health Canada’s Access to Cannabis for Medical Purposes Regulations and distributes globally. Our goal is to establish the most valuable international cannabis community comprised of passionate, daring people, driven by quality and integrity, who are determined to write history, not read about it.
Numbers (USD)
| Market Cap | 1,915,000,000 |
| Total Revenue (year ended 12/31/2017) | 4,082,000 |
| Gross Profit | 7,230,000 |
| Operating Income (Loss) | (2,108) |
| Last price (10/1/2018) | 11.32 |
| 52 Week high/low | 5.12 - 15.30 |
iANthus Capital Holdings Inc. (OTC: ITHUF)
Summary
From website (https://www.ianthuscapital.com): iAnthus Capital owns and operates licensed cannabis cultivators, processors and dispensaries throughout the United States. Founded by entrepreneurs with decades of experience in operations, capital markets, corporate finance, law and healthcare services, iAnthus provides a unique combination of capital and hands-on operating and management expertise to create unparalleled value for its shareholders. iAnthus allocates resources to each step of the operational process to achieve maximum growth.
Numbers (USD)
| Market Cap | 410,345,000 |
| Total Revenue (year ended 12/31/2017) | 2,407,229 |
| Gross Profit | 106,714 |
| Operating Income (Loss) | (7,415,918) |
| Last price (10/1/2018) | 5.93 |
| 52 Week high/low | 1.33 - 7.27 |
Aleafia Health Inc. (TSXV: ALEF.V)
Summary
From website (https://www.aleafiainc.com): Aleafia Health brings Canadians medical cannabis care through nationwide clinics, world-class cultivation and distribution facilities, and innovative research. Experiential knowledge of medical cannabis therapy, a rapidly evolving science, helps ensure physicians make recommendations that have been proven effective through historical data, helping to avoid treatments based on trial and error. The company’s staff of trained educators provide learning sessions for new patients, providing ongoing consultation ensuring patients are matched with the most appropriate treatment.
Numbers (CAD)
| Market Cap | 424,258,000 |
| Total Revenue | |
| Gross Profit | |
| Operating Income (Loss) | |
| Last price (10/1/2018) | 3.07 |
| 52 Week high/low | 0.47 - 4.70 |
CannTrust Holdings Inc. (TRST.TO)
Summary
From their website (https://canntrust.ca): CannTrust is a federally regulated licensed producer, who brings more than 40 years of pharmacy and healthcare experience to the Medical Cannabis industry. We apply this expertise to produce 100% pesticide free standardized Medical Cannabis for patients in need.
At CannTrust™ we are committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive pharma partner Apotex are diligently innovating and developing products. CannTrust has been granted a Section 9 License by Health Canada under the Narcotic Control Regulations. This allows us to expand our product development and research to include pharmaceuticals in an effort to make it easier for patients to use Medical Cannabis today and in the future.
Our onsite laboratory with advanced technology and equipment for testing and research on the medical use of cannabis provides CannTrust with the ability to develop and rigorously test our products at any point.
We continue to evolve our patient and medical practitioner education program about Medical Cannabis, and have an industry leading compassionate use program to support patients with financial needs.
We continue to expand to ensure we have a continuous supply of quality standardized products and superior customer service. Our original 50,000-square foot state-of-the-art hydroponic facility is home to cultivating, processing extracts and our distribution center.
Our second facility is a 430,000-square foot greenhouse in the heart of the Niagara region. The facility is the first of its kind in the Canadian Cannabis industry to be designed and engineered using advanced perpetual growing technology. This facility is one of the largest in North America, with Phase 1 completed and Phase 2 to come on-stream in mid 2018.
Numbers (CAD)
| Market Cap | 1,235,000,000 |
| Total Revenue (year ended 12/31/2017) | 20,697,764 |
| Gross Profit | 25,233,058 |
| Operating Income (Loss) | 9,212,963 |
| Last price (10/1/2018) | 12.45 |
| 52 Week high/low | 5.86 - 13.84 |
New Age Beverages Corp. (NASDAQ: NBEV)
Summary
From their website (https://newagebev.com): New Age Beverages Company fuels health-conscious consumers with a diversified, all-natural, functional, beverage portfolio spanning numerous product categories, sales channels, and consumer demographics. A purpose-driven company, delivering healthy alternatives to consumers and empowering them to collectively participate in the growing ‘better for you’ movement.
Numbers (USD)
| Market Cap | 382,344,000 |
| Total Revenue (year ended 12/31/2017) | 52,188,295 |
| Gross Profit | 12,399,911 |
| Operating Income (Loss) | (6,049,053) |
| Last price (10/1/2018) | 8.95 |
| 52 Week high/low | 1.30 - 9.99 |
Level Brands Inc. (NYSE: LEVB)
Summary
From their website (https://levelbrands.com): Level Brands creates bold, unconventional and socially responsible branding for leading businesses. With a focus on consumer products marketing beauty, fashion and entertainment, Level Brands designs companies that disrupts industries to redefine leaders. Amongst a portfolio of other brands, this press release illustrates their reason for being on this list:
CHARLOTTE, N.C.– (BUSINESS WIRE)–Sep. 21, 2018 – Level Brands, Inc. (NYSE American: LEVB), an innovative marketing and licensing company that provides bold, unconventional, and socially responsible branding for leading businesses, through its licensing agreement with Isodiol International, Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6A.F), is pleased to announce the online launch of five new cannabidiol (CBD) products under the kathy ireland® Health & Wellness brand.
In January 2018, Level Brands and Isodiol signed a 10 year license agreement to work together to develop consumer products for kathy ireland® Health & Wellness, a licensor to Level Brands. The five supplements are available online at: https://isodiol.com/kathyireland/. The products are expected to be available at additional online and in-store retailers nationwide in the coming months.
Numbers (USD)
| Market Cap | 48,500,000 |
| Total Revenue (year ended 9/30/2017) | 4,474,953 |
| Gross Profit | 3,119,381 |
| Operating Income (Loss) | (239,291) |
| Last price (10/1/2018) | 5.99 |
| 52 Week high/low | 2.74 - 24.91 |
Cannabis Sativa Inc. (OTC: CBDS)
Summary
From their website (https://cannabissativainc.com): It is our ambition to brand and market the highest quality, legal cannabis & hemp products – and to innovate for tomorrow. We foresee a future where the hi Brand is synonymous with the highest quality and best value in the space; a vision we plan to support through aggressive marketing and strategic alliances.
Cannabis Sativa, Inc. is Marijuana & Industrial Hemp, and we’re prepared to shape its future in a legal environment. We’ve assembled the team, the talent and the experience necessary to brand and market the highest-quality cannabis products available today – and to innovate the future of casual cannabis and industrial hemp products.
Numbers (USD)
| Market Cap | 113,456,000 |
| Total Revenue (year ended 12/31/2017) | 317,985 |
| Gross Profit | 163,534 |
| Operating Income (Loss) | (6,866,144) |
| Last price (10/1/2018) | 5.84 |
| 52 Week high/low | 1.92 - 9.74 |
Market Cap Ranking
Market Cap (Adjusted to USD)
| Tilray, Inc. (TLRY) | 15,066,000,000 |
| Canopy Growth Corporation (CGC) | 10,801,000,000 |
| Aurora Cannabis Inc. (ACBFF) | 9,036,000,000 |
| Cronos Group Inc. (CRON) | 1,915,000,000 |
| CannTrust Holdings Inc. (TRST.TO) | 963,300,000 |
| iAnthus Capital Holdings, Inc. (ITHUF) | 410,345,000 |
| New Age Beverages Corporation (NBEV) | 382,344,000 |
| India Globalization Capital, Inc. (IGC) | 358,492,000 |
| Aleafia Health Inc. (ALEF.V) | 330,921,240 |
| Cannabis Sativa, Inc. (CBDS) | 113,456,000 |
| Valens Groworks Corp. (MYMSF) | 102,871,000 |
| Level Brands, Inc. (LEVB) | 48,500,000 |
Revenue Ranking
Revenue (total/last reported year) (Adjusted to USD)
| Canopy Growth Corporation (CGC) | 77,948,000 |
| Aurora Cannabis Inc. (ACBFF) | 55,196,000 |
| New Age Beverages Corporation (NBEV) | 52,188,295 |
| CannTrust Holdings Inc. (TRST.TO) | 16,144,256 |
| Tilray, Inc. (TLRY) | 20,538,000 |
| Level Brands, Inc. (LEVB) | 4,474,953 |
| Cronos Group Inc. (CRON) | 4,082,000 |
| iAnthus Capital Holdings, Inc. (ITHUF) | 2,407,229 |
| India Globalization Capital, Inc. (IGC) | 2,192,590 |
| Cannabis Sativa, Inc. (CBDS) | 317,985 |
| Valens Groworks Corp. (MYMSF) | 40,724 |
| Aleafia Health Inc. (ALEF.V) | NA |
Notes: Some numbers reflect intra-day variance in price
Sources: Company data, company sites, NYSE, NASDAQ, Yahoo Finance
This is not investment advice nor a recommendation
For more information or questions, please email info@rezzn.com
All Blog Posts
First we change Arizona, then we change America!
Tuesday, January 26, 2021
Can you smoke old, dried out weed?
Thursday, August 6, 2020
How to Avoid Getting Too High on Edibles
Saturday, August 1, 2020
Ganja Yoga: Getting High Before You Flow
Friday, July 24, 2020
Stoners Accused of Being Lazy Love to Get High and Clean!
Tuesday, July 21, 2020
A Lesson (Or Two) on How to Obtain a Medical Marijuana Card
Wednesday, July 15, 2020
Tips For New Cannabis Users
Wednesday, July 15, 2020
Wolverines!!!
Wednesday, April 1, 2020
Cannabis Stocks Snapshot
Monday, October 15, 2018
Will Europe Be at The Forefront of Future Legal Cannabis?
Wednesday, August 15, 2018